Get the latest tech news
Psychedelics could treat some of the worst chronic pain in the world
Decades of citizen science are finally translating into clinical trials for psychedelic pain treatments.
“I cannot tell you how hard we’ve had to push in the last four years to get this into the discussion,” said Wing, who cofounded the PPA alongside Psychedelics Today CEO Joe Moore and Bob Wold, the founder of Clusterbusters. It outlines a few areas: digging into the potential mechanisms of action, whether micro- or macro-doses are more effective, whether complementary therapies should be included, expanding the search for conditions that may benefit, and the logistical thicket of treatment protocols. State decriminalization efforts, along with investments in harm reduction and public education, can reduce the risks around criminalizing people seeking psychedelic treatments while the FDA approval process churns along.
Or read this on Hacker News
